SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Incyte Corporation (INCY)

NEW YORK, April 20, 2017 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Incyte Corporation ("Incyte" or the "Company") (NASDAQ: INCY). Such investors are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/incy.

The investigation concerns whether Del Taco and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.

On April 14, 2017, Incyte revealed that the U.S. Food and Drug Administration ("FDA") had rejected the new drug application for baricitinib, a once-daily rheumatoid arthritis treatment developed in collaboration with Eli Lilly and Company.  Incyte informed investors that the FDA asked for additional data to "characterize safety concerns across treatment arms" and to determine "the most appropriate doses."  Following this news, Incyte stock dropped $14.77 per share, or 10.49%, to close at $126.07 on April 17, 2017.

If you are aware of any facts relating to this investigation, or purchased shares of Incyte, you can assist this investigation by visiting the firm's site: www.bgandg.com/incy. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484. 

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.  Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.  In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration.   Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | [email protected]

SOURCE Bronstein, Gewirtz & Grossman, LLC

Related Links

http://www.bgandg.com